Spence AM - Search Results

1

Challenges in clinical studies with multiple imaging probes.

Krohn KA, O'Sullivan F, Crowley J, Eary JF, Linden HM, Link JM, Mankoff DA, Muzi M, Rajendran JG, Spence AM, Swanson KR. Krohn KA, et al. Among authors: spence am. Nucl Med Biol. 2007 Oct;34(7):879-85. doi: 10.1016/j.nucmedbio.2007.07.014. Nucl Med Biol. 2007. PMID: 17921038 Free PMC article. Review.

2

1-[Carbon-11]-glucose radiation dosimetry and distribution in human imaging studies.

Graham MM, Peterson LM, Muzi M, Graham BB, Spence AM, Link JM, Krohn KA. Graham MM, et al. Among authors: spence am. J Nucl Med. 1998 Oct;39(10):1805-10. J Nucl Med. 1998. PMID: 9776292 Free article.

3

Kinetic characterization of hexokinase isoenzymes from glioma cells: implications for FDG imaging of human brain tumors.

Muzi M, Freeman SD, Burrows RC, Wiseman RW, Link JM, Krohn KA, Graham MM, Spence AM. Muzi M, et al. Among authors: spence am. Nucl Med Biol. 2001 Feb;28(2):107-16. doi: 10.1016/s0969-8051(00)00201-8. Nucl Med Biol. 2001. PMID: 11295420

4

Hypoxia imaging-directed radiation treatment planning.

Rajendran JG, Hendrickson KR, Spence AM, Muzi M, Krohn KA, Mankoff DA. Rajendran JG, et al. Among authors: spence am. Eur J Nucl Med Mol Imaging. 2006 Jul;33 Suppl 1:44-53. doi: 10.1007/s00259-006-0135-1. Eur J Nucl Med Mol Imaging. 2006. PMID: 16763816 Review.

5

18F-FDG PET of gliomas at delayed intervals: improved distinction between tumor and normal gray matter.

Spence AM, Muzi M, Mankoff DA, O'Sullivan SF, Link JM, Lewellen TK, Lewellen B, Pham P, Minoshima S, Swanson K, Krohn KA. Spence AM, et al. J Nucl Med. 2004 Oct;45(10):1653-9. J Nucl Med. 2004. PMID: 15471829 Free article. Clinical Trial.

6

True tracers: comparing FDG with glucose and FLT with thymidine.

Krohn KA, Mankoff DA, Muzi M, Link JM, Spence AM. Krohn KA, et al. Among authors: spence am. Nucl Med Biol. 2005 Oct;32(7):663-71. doi: 10.1016/j.nucmedbio.2005.04.004. Nucl Med Biol. 2005. PMID: 16243640 Review.

7

Kinetic analysis of 3'-deoxy-3'-18F-fluorothymidine in patients with gliomas.

Muzi M, Spence AM, O'Sullivan F, Mankoff DA, Wells JM, Grierson JR, Link JM, Krohn KA. Muzi M, et al. Among authors: spence am. J Nucl Med. 2006 Oct;47(10):1612-21. J Nucl Med. 2006. PMID: 17015896 Free article.

8

What is in a number? The FDG lumped constant in the rat brain.

Krohn KA, Muzi M, Spence AM. Krohn KA, et al. Among authors: spence am. J Nucl Med. 2007 Jan;48(1):5-7. J Nucl Med. 2007. PMID: 17204692 Free article. No abstract available.

9

Tumor-specific positron emission tomography imaging in patients: [18F] fluorodeoxyglucose and beyond.

Mankoff DA, Eary JF, Link JM, Muzi M, Rajendran JG, Spence AM, Krohn KA. Mankoff DA, et al. Among authors: spence am. Clin Cancer Res. 2007 Jun 15;13(12):3460-9. doi: 10.1158/1078-0432.CCR-07-0074. Clin Cancer Res. 2007. PMID: 17575208 Review.

10

Contribution of labeled carbon dioxide to PET imaging of carbon-11-labeled compounds.

Shields AF, Graham MM, Kozawa SM, Kozell LB, Link JM, Swenson ER, Spence AM, Bassingthwaighte JB, Krohn KA. Shields AF, et al. Among authors: spence am. J Nucl Med. 1992 Apr;33(4):581-4. J Nucl Med. 1992. PMID: 1552344 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

153 results

Search Page